Heterogeneity of enterochromaffin cells within the gastrointestinal tract

Neurogastroenterology and Motility

Volumn 29, Issue 6, 2017, Pages

  Diwakarla, S ^a,b   Fothergill, L J ^a   Fakhry, J ^a   Callaghan, B ^a   Furness, J B ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

5 hydroxytryptamine; enteroendocrine cells; gut hormones; serotonin

Indexed keywords

SEROTONIN;

CELIAC DISEASE; CELL HETEROGENEITY; DISEASE ASSOCIATION; ENTEROCHROMAFFIN CELL; GASTROINTESTINAL TRACT; HUMAN; IRRITABLE COLON; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CYTOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CELIAC DISEASE; ENTEROCHROMAFFIN CELLS; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME;

EID: 85019044993     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.13101     Document Type: Review

References (34)

1. Sjölund K, Sandén G, Håkanson R, Sundler F. Endocrine cells in the human intestine: an immunocytochemical study. Gastroenterology. 1983;85:1120-1130.
2. de Herder WW, Rehfeld JF, Mark Kidd M, Irvin M, Modlin IM. A short history of neuroendocrine tumours and their peptide hormones. Best Pract Res Clin Endocrinol Metab 2016;30:3-17.
3. Vialli M, Erspamer V. Celluli enterocromaffini e cellule basigranulose acidofile nei vertebrati. Z Zellforsch. 1933;19:743-773.
4. Erspamer V, Asero B. Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature. 1952;169:800-801.
5. Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Op Endoc Diab Obes. 2013;20:14-21.
6. Cetin Y. Secretin-cells of the mammalian intestine contain serotonin. Histochemistry. 1990;93:601-606.
7. Roth KA, Gordon JI. Spatial differentiation of the intestinal epithelium: analysis of enteroendocrine cells containing immunoreactive serotonin, secretin, and substance P in normal and transgenic mice. Proc Natl Acad Sci USA. 1990;87:6408-6412.
8. Coate KC, Kliewer SA, Mangelsdorf DJ. SnapShot: hormones of the gastrointestinal tract. Cell. 2014;159:1478-1479.
9. Mawe GM, Hoffman JM. Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10:473-486.
10. Martin AM, Lumsden AL, Young RL, Jessup CF, Spencer NJ, Keating DJ. The nutrient-sensing repertoires of mouse enterochromaffin cells differ between duodenum and colon [published online March 2 2017]. Neurogastroenterol Motil. 2017. https://doi.org/10.1111/nmo.13046.
11. Lopez MJ, Upchurch BH, Rindi G, Leiter AB. Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types. J Biol Chem. 1995;270:885-891.
12. Rindi G, Ratineau C, Ronco A, Candusso ME, Tsai M-J, Leiter AB. Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine. Development. 1999;126:4149-4156.
13. Cho H-J, Callaghan B, Bron R, Bravo DM, Furness JB. Identification of enteroendocrine cells that express TRPA1 channels in the mouse intestine. Cell Tissue Res. 2014;356:77-82.
14. Fakhry J, Wang J, Martins P, et al. Distribution and characterisation of CCK containing enteroendocrine cells of the mouse small and large intestine. Cell Tissue Res. (In press, Accepted 20 March 2017)
15. Lukinius AIC, Ericsson JLE, Lundqvist MK, Wilander EMO. Ultrastructural localization of serotonin and polypeptide YY (PYY) in endocrine cells of the human rectum. J Histochem Cytochem. 1986;34:719-726.
16. Martins P, Fakhry J, Chaves de Oliveira E, et al. Analysis of eneteroendocrine cell populations in the human colon. Cell Tissue Res. 2017;367:361-368.
17. Hörsch D, Fink T, Göke B, Arnold R, Büchler M, Weihe E. Distribution and chemical phenotypes of neuroendocrine cells in the human anal canal. Regul Pept. 1994;54:527-542.
18. Li Y, Owyang C. Pancreatic secretion evoked by cholecystokinin and non-cholecystokinin-dependent duodenal stimuli via vagal afferent fibes in the rat. J Physiol (Lond). 1996;494:773-782.
19. Li Y, Hao Y, Zhu J, Owyang C. Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats. Gastroenterology. 2000;118:1197-1207.
20. Ellis M, Chambers JD, Gwynne RM, Bornstein JC. Serotonin and cholecystokinin mediate nutrient-induced segmentation in guinea pig small intestine. Am J Physiol Gastrointest Liver Physiol. 2013;304:G749-G761.
21. Morley JE. Appetite regulation by gut peptides. Annu Rev Nutr. 1990;10:383-395.
22. Blundell JE. Serotonin manipulations and the structure of feeding behaviour. Appetite. 1986;7:39-56.
23. Cooper SJ, Dourish CT. Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding. Physiol Behav. 1990;48:849-857.
24. 4-dependent pathway. Scand J Gastroenterol. 2006;41:1279-1289.
25. Tuo B-G, Isenberg JI. Effect of 5-hydroxytryptamine on duodenal mucosal bicarbonate secretion in mice. Gastroenterology. 2003;125:805-814.
26. Reynaud Y, Fakhry J, Fothergill L, et al. The chemical coding of 5-hydroxytryptamine containing enteroendocrine cells in the mouse gastrointestinal tract. Cell Tissue Res. 2016;364:489-497.
27. Cho H-J, Kosari S, Hunne B, et al. Differences in hormone localisation patterns of K and L type enteroendocrine cells in the mouse and pig small intestine and colon. Cell Tissue Res. 2015;359:693-698.
28. Coleman NS, Foley S, Dunlop SP, et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol. 2006;4:874-881.
29. Di Sabatino A, Giuffrida P, Vanoli A, et al. Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease. Am J Gastroenterol. 2014;109:258-269.
30. Dunlop SP, Coleman NS, Blackshaw E, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005;3:349-357.
31. Park JH, Rhee P-L, Kim G, et al. Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2006;18:539-546.
32. Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Effects of 5-hydroxytryptamine (Serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol. 2008;6:545-555.
33. Brown PM, Drossman DA, Wood AJJ, et al. The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology. 2011;141:507-516.
34. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355-366.